Antioxidant potential of curcumin-a meta-analysis of randomized clinical trials
Primary antibodies against SLC7A11 (Cell Signaling Technology, 12691, 1:500 dilution), iNOS (BD Biosciences, 610329, 1:500 dilution), 15LO1 (Abnova, H00000246-D01P, 1:1000 dilution), GPX4 (Abcam, 125066, 1:1000 dilution), POSTN (Santa Cruz Biotechnology, 67233, 1:500), and CCL26 (R&D Systems, AF653, 1:500 dilution) were used
One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims
The identification and targeting of specific biomarkers presents a promising avenue for the diagnosis, clinical management, and prognostic assessment of ovarian cancer